The deal with Tubulis gives Gilead access to the German biotech's ADC technology platform, designed to make ADCs more stable, ...
TipRanks on MSN8d
Shanghai Henlius Biotech Advances in Cancer TreatmentShanghai Henlius Biotech, Inc. Class H (HK:2696) has released an update. Shanghai Henlius Biotech, Inc. has received approval from China’s ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback